Decision to close the Obihiro office in Hokkaido and recognition of an impairment loss
First written in FY2017. 3 of 8 entries say "Advanced", first in FY2019. Latest entry: 2026-04-27.
1 other company's latest entry also says "Advanced".
- 2026-04-27AdvancedEarnings
「Active capital investment is being made in emerging technology fields such as robotic surgery and arrhythmia treatment, and our Group is strengthening personnel development and other measures to respond appropriately to the expansion of these markets.」
The response to emerging technology fields such as robotic surgery and arrhythmia treatment was developed into stronger personnel-development initiatives. - FY2022-Q3RestatedAnnual report
「Impairment loss — 18,770」
The impairment loss of ¥18.770 million recorded in the cumulative second-quarter period was also recorded under extraordinary losses in the cumulative third-quarter period. - FY2022-Q2Quarterly impairment loss recognitionAnnual report
「Impairment loss — 18,770」
An impairment loss of ¥18.770 million was recorded in the cumulative second-quarter period. The filing does not identify the assets concerned or provide details of the decision-making process. - FY2022-Q1Quarterly impairment loss recognitionAnnual report
「Impairment loss — 14,000」
An impairment loss of ¥14.000 million was recorded in the first quarter. The filing does not identify the assets concerned or provide details of the decision-making process. - FY2020AdvancedAnnual report
「During the consolidated fiscal year, the Company decided to relocate the relevant asset. As a result, the carrying amount of the asset group was reduced to its recoverable amount, and the reduction of ¥191.287 million was recorded as an impairment loss under extraordinary losses.」
Following the idle assets in Takamatsu in the previous fiscal year, the Company decided to relocate sales facilities in Tobe, Iyo District, Ehime, and recorded an impairment loss of ¥191.287 million. - FY2019AdvancedAnnual report
「During the consolidated fiscal year, the Company decided to relocate the relevant asset. As a result, the carrying amount of the asset group was reduced to its recoverable amount, and the reduction of ¥86.276 million was recorded as an impairment loss under extraordinary losses.」
Following the closure and liquidation of the Obihiro, Hokkaido business site and other locations, the Company decided to relocate idle assets in Takamatsu, Kagawa, and recorded an impairment loss of ¥86.276 million. - FY2018AchievedAnnual report
「㈱オオタメディカル, formerly a consolidated subsidiary of the Company, completed its liquidation on 30 March 2018 and was therefore excluded from the scope of consolidation from the current consolidated fiscal year.」
The liquidation of オオタメディカル was completed, and the company was excluded from the scope of consolidation. - FY2017First statedAnnual report
「During the consolidated fiscal year, the Company decided to close a business site. As the assets were no longer expected to be used in the future, the carrying amount of the asset group was reduced to its recoverable amount, and the reduction of ¥14.422 million was recorded as an impairment loss under extraordinary losses.」
The Company decided to close sales facilities and employee housing in Obihiro, Hokkaido, and recorded an impairment loss of ¥14.422 million.